Properties
Description
Aplaviroc specifically binds to chemokine receptors. This binding blocks the receptors and prevents the corresponding chemokines from exerting their effects on immune cells, leading to reduced chemotaxis and cell activation.
Molecular Formula
C33H43N3O6
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Aplaviroc can be applied in the study of its efficacy as a CCR5 antagonist in HIV-1 infection.